These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 1338053)
1. Excitatory amino acids and neuronal plasticity: modulation of AMPA receptors as a novel substrate for the action of nootropic drugs. Nicoletti F; Casabona G; Genazzani AA; Copani A; Aleppo G; Canonico PL; Scapagnini U Funct Neurol; 1992; 7(5):413-22. PubMed ID: 1338053 [TBL] [Abstract][Full Text] [Related]
2. Member of the Ampakine class of memory enhancers prolongs the single channel open time of reconstituted AMPA receptors. Suppiramaniam V; Bahr BA; Sinnarajah S; Owens K; Rogers G; Yilma S; Vodyanoy V Synapse; 2001 May; 40(2):154-8. PubMed ID: 11252027 [TBL] [Abstract][Full Text] [Related]
3. Effects of D-cycloserine and aniracetam on spatial learning in rats with entorhinal cortex lesions. Zajaczkowski W; Danysz W Pharmacol Biochem Behav; 1997 Jan; 56(1):21-9. PubMed ID: 8981605 [TBL] [Abstract][Full Text] [Related]
4. The mechanism of action of aniracetam at synaptic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors: indirect and direct effects on desensitization. Lawrence JJ; Brenowitz S; Trussell LO Mol Pharmacol; 2003 Aug; 64(2):269-78. PubMed ID: 12869631 [TBL] [Abstract][Full Text] [Related]
6. Effects of thiol-reagents on [3H]alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid binding to rat telencephalic membranes. Terramani T; Kessler M; Lynch G; Baudry M Mol Pharmacol; 1988 Aug; 34(2):117-23. PubMed ID: 2901029 [TBL] [Abstract][Full Text] [Related]
7. Receptor changes and LTP: an analysis using aniracetam, a drug that reversibly modifies glutamate (AMPA) receptors. Staubli U; Ambros-Ingerson J; Lynch G Hippocampus; 1992 Jan; 2(1):49-57. PubMed ID: 1339192 [TBL] [Abstract][Full Text] [Related]
8. Selectivity of amino acid transmitters acting at N-methyl-D-aspartate and amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors. Curras MC; Dingledine R Mol Pharmacol; 1992 Mar; 41(3):520-6. PubMed ID: 1372086 [TBL] [Abstract][Full Text] [Related]
9. Interactions among GYKI-52466, cyclothiazide, and aniracetam at recombinant AMPA and kainate receptors. Johansen TH; Chaudhary A; Verdoorn TA Mol Pharmacol; 1995 Nov; 48(5):946-55. PubMed ID: 7476926 [TBL] [Abstract][Full Text] [Related]
10. Differential modulation by cyclothiazide and concanavalin A of desensitization at native alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid- and kainate-preferring glutamate receptors. Wong LA; Mayer ML Mol Pharmacol; 1993 Sep; 44(3):504-10. PubMed ID: 7690448 [TBL] [Abstract][Full Text] [Related]
11. Agonist- and subunit-dependent potentiation of glutamate receptors by a nootropic drug aniracetam. Tsuzuki K; Takeuchi T; Ozawa S Brain Res Mol Brain Res; 1992 Nov; 16(1-2):105-10. PubMed ID: 1281252 [TBL] [Abstract][Full Text] [Related]
12. Selective effects of aniracetam across receptor types and forms of synaptic facilitation in hippocampus. Xiao P; Staubli U; Kessler M; Lynch G Hippocampus; 1991 Oct; 1(4):373-80. PubMed ID: 1688280 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of rat brain glutamate receptors by philanthotoxin. Ragsdale D; Gant DB; Anis NA; Eldefrawi AT; Eldefrawi ME; Konno K; Miledi R J Pharmacol Exp Ther; 1989 Oct; 251(1):156-63. PubMed ID: 2571715 [TBL] [Abstract][Full Text] [Related]
14. Nootropic agents enhance the recruitment of fast GABAA inhibition in rat neocortex. Ling DS; Benardo LS Cereb Cortex; 2005 Jul; 15(7):921-8. PubMed ID: 15459084 [TBL] [Abstract][Full Text] [Related]